GW PHARMACEUTICALS PLC's ticker is GWPH and the CUSIP is 36197T103.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2018 | $3,628,000 | +23.8% | 21,000 | 0.0% | 0.04% | +25.7% |
| Q2 2018 | $2,930,000 | -64.9% | 21,000 | -71.6% | 0.04% | -66.0% |
| Q1 2018 | $8,338,000 | +42.3% | 74,000 | +66.7% | 0.10% | +39.2% |
| Q4 2017 | $5,861,000 | -89.7% | 44,400 | -92.1% | 0.07% | -86.4% |
| Q3 2017 | $56,943,000 | +1.2% | 561,071 | 0.0% | 0.54% | -7.8% |
| Q2 2017 | $56,247,000 | -2.3% | 561,071 | +17.9% | 0.59% | -9.5% |
| Q1 2017 | $57,555,000 | +29.9% | 475,900 | +20.0% | 0.65% | +15.4% |
| Q4 2016 | $44,320,000 | +822.4% | 396,600 | +995.6% | 0.56% | +927.3% |
| Q3 2016 | $4,805,000 | -65.1% | 36,200 | -81.0% | 0.06% | -62.1% |
| Q1 2016 | $13,752,000 | -34.9% | 190,600 | -37.3% | 0.14% | -24.1% |
| Q4 2015 | $21,117,000 | -38.7% | 304,100 | -19.4% | 0.19% | -45.1% |
| Q3 2015 | $34,456,000 | -13.7% | 377,100 | +16.0% | 0.35% | +18.8% |
| Q2 2015 | $39,923,000 | +116.9% | 325,000 | +60.9% | 0.29% | +86.6% |
| Q1 2015 | $18,408,000 | +3.0% | 202,000 | -8.6% | 0.16% | -16.0% |
| Q3 2014 | $17,868,000 | +215.1% | 221,000 | +131.4% | 0.19% | +167.1% |
| Q1 2014 | $5,670,000 | -57.4% | 95,500 | -70.2% | 0.07% | -64.1% |
| Q4 2013 | $13,301,000 | – | 320,200 | – | 0.20% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|